AMARIN CORP PLC\UK
AMRNNasdaqHealthcare · Pharmaceutical Preparations · X0 · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $213.6M | $228.6M | $306.9M | $369.2M | $583.2M | $614.1M |
| Operating income | −$50.2M | −$91.8M | −$67.6M | −$105.9M | $10.5M | −$19.7M |
| Net income | −$38.8M | −$82.2M | −$59.1M | −$105.8M | $7.7M | −$18.0M |
| Total assets | $670.8M | $685.3M | $831.7M | $886.2M | $1.07B | $966.0M |
| Total liabilities | $211.5M | $199.2M | $279.6M | $290.8M | $401.0M | $338.5M |
| Equity | $459.3M | $486.2M | $552.1M | $595.3M | $667.1M | $627.5M |
| EPS (diluted) | $-0.09 | $-0.20 | $-0.15 | $-0.26 | $0.02 | $-0.05 |
| Shares out. | 416.2M | 411.6M | 408.8M | 408.8M | 396.6M | 392.5M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −23.5%
- Net margin
- −18.2%
- Return on equity
- −8.4%
- Return on assets
- −5.8%
- Return on capital (ROCE)
- −10.5%
- Liabilities / assets
- 31.5%
- Debt / equity
- 0.46×
- Book value / share
- $1.10
- Revenue growth (YoY)
- −6.5%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -2.07distress
- Accruals / assets
- −6.8%clean
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 3 warning● 3 good- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Sarissa Capital Management LpActivist (13D)Mar 25, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 620,219 | 8.8 | -8.0% |
| Apr 30, 2026 | 673,967 | 7.2 | +57.9% |
| Apr 15, 2026 | 426,751 | 11.7 | -6.3% |
| Mar 31, 2026 | 455,457 | 10.1 | +1.9% |
| Mar 13, 2026 | 446,956 | 4.8 | +1.9% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Shareholder voteMay 15, 2026
- Results of operationsApr 29, 2026
- Director / officer changeMar 27, 2026
- Results of operationsFeb 25, 2026
- Results of operationsJan 8, 2026
- Results of operationsOct 29, 2025
- Director / officer changeOct 22, 2025
- Results of operationsJul 30, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.